GERN
Geron Corp
Price:  
4.45 
USD
Volume:  
4,827,757.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN Relative Valuation

-296.0%
Upside

As of 2024-09-13, the Relative Valuation of Geron Corp (GERN) is (8.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.45 USD, the upside of Geron Corp based on Relative Valuation is -296.0%.

The range of the Relative Valuation is (5.22) - (7.55) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 14.3x - 45.9x 29.7x
Forward P/E multiples 10.3x - 20.7x 18.2x
Fair Price (5.22) - (7.55) (8.72)
Upside -217.4% - -269.6% -296.0%
4.45 USD
Stock Price
(8.72) USD
Fair Price

GERN Relative Valuation - Historical P/E Data

Date P/E
2024-09-12 -12.22
2024-09-11 -12.05
2024-09-10 -11.92
2024-09-09 -12.11
2024-09-06 -11.67
2024-09-05 -11.75
2024-09-04 -11.78
2024-09-03 -12.08
2024-08-30 -13.04
2024-08-29 -12.52
2024-08-28 -12.38
2024-08-27 -12.79
2024-08-26 -12.52
2024-08-23 -12.46
2024-08-22 -12.30
2024-08-21 -12.46
2024-08-20 -12.68
2024-08-19 -12.25
2024-08-16 -12.35
2024-08-15 -12.25
2024-08-14 -12.19
2024-08-13 -12.55
2024-08-12 -12.99
2024-08-09 -12.90
2024-08-08 -12.63
2024-08-07 -12.52
2024-08-06 -12.63
2024-08-05 -12.38
2024-08-02 -12.55
2024-08-01 -13.12
2024-07-31 -13.01
2024-07-30 -12.88
2024-07-29 -12.88
2024-07-26 -12.79
2024-07-25 -11.78
2024-07-24 -11.78
2024-07-23 -12.68
2024-07-22 -12.85
2024-07-19 -12.63
2024-07-18 -12.82
2024-07-17 -13.07
2024-07-16 -13.70
2024-07-15 -13.45
2024-07-12 -12.93
2024-07-11 -13.07
2024-07-10 -12.63
2024-07-09 -12.57
2024-07-08 -12.44
2024-07-05 -12.44
2024-07-03 -11.97